Global Herpes Market is expected to grow with the CAGR of 6.6% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-herpes-market
Global herpes market is highly consolidated and includes specific number of key players. The market has witnessed increased strategic developments owing to favorable market scenario.
Major players dealing in the global herpes market are introducing a wide range of products and adopting strategic initiatives, such as acquisitions, agreements, into the market. This has helped companies maximize their sales with enhance their product portfolio.
GlaxoSmithKline plc, is the dominating player in the global herpes market. Other key players existing in the market include Abbott, Apotex, Inc., Avet Pharmaceuticals, Inc., Bausch Health Companies, Inc. Cipla, Inc., Dr. Reddy’s Laboratories Ltd., EPI Health, Fresenius Kabi AG, GlaxoSmithKline plc., Glenmark Pharmaceutical Inc., USA, Maruho Co.,Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc., RECORDATI S.p.A., Aurobindo Pharma, Amneal Pharmaceuticals LLC, Slavia Pharm S.R.L., and Blistex, Inc. among others.
GlaxoSmithKline plc was established in 1715, and headquartered in London. The company is engaged in the research development and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It has following business segments including pharmaceuticals, vaccines, and consumer healthcare, in which pharmaceuticals is the market focused segment. The company also provides various product categories including prescription medicines. Vaccines, consumer healthcare products, ViiV healthcare, and Stiefel dermatology in which the market focused products lie under prescription medicines and Vaccines.
The company has wide presence in North America, South America, Asia-Pacific, Middle East, and Africa. The company also has subsidiaries companies such as Barrier Therapeutics, Inc (US), GlaxoSmithKline – Produtos Farmaceuticos, Limitada (Portugal), GlaxoSmithKline Biologicals Kft. (Hungary), and GlaxoSmithKline Consumer Holding B.V. (Netherlands) among others.
Viatris Inc. was founded in 1961 and headquartered in Pennsylvania, U.S. The company works in the healthcare domain with the production of drugs including prescription generic, branded generic, brand-name and biosimilar drugs, as well as over-the counter remedies. It offers a variety of products such as therapeutic areas, brands, biosimilar, generics, over-the-counter and API, in which the market focused products lie under generics. The company has initiated many strategic initiatives to expand its market.
The company has wide presence across North America, Europe, South America, Asia-Pacific, Middle East and Africa. It also has various subsidiary companies including Agila Australasia Pty Ltd (Australia), Alphapharm Pty. Ltd. (Australia), Meda Pharmaceuticals Pty Ltd (Australia), Mylan Australia Holding Pty Ltd (Australia), Mylan Health Pty. Ltd. (Australia), and Arcana Arzneimittel GmbH (Austria) among others.
Fresenius Kabi AG
Fresenius Kabi AG was founded in 1999 and headquartered in Bad Homburg, Germany. The company specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. It has following business segments including Fresenius Medical Care, Fresenius kabi, Fresnius Helios, and Fresnius Vamed in which Fresenius Kabi is the market focused segment. The company also provides various product categories including animal health, biosimilars, colloids, compounding, infusion technology, IV drugs, parenteral nutrition, standard solutions, and transfusion technology, in which the market focused products lie under IV drugs. The company has initiated many strategic initiatives to expand its market.
The company has wide presence across Americas, Europe, Asia-Pacific, Oceania, and Middle East and Africa. It has various subsidiary companies such as HELIOS Kliniken GmbH (Germany), Curalie GmbH (Germany), Else Kröner-Fresenius-Stiftung (Germany), Vamed Management Und Service Gmbh Deutschland (Germany), and Calea Ltd. (Canada) among others.
Global Herpes Market – Industry Trends and Forecast to 2028
Asia-Pacific Herpes Market – Industry Trends and Forecast to 2028
Middle East and Africa Herpes Market – Industry Trends and Forecast to 2028
Europe Herpes Market – Industry Trends and Forecast to 2028
North America Herpes Market – Industry Trends and Forecast to 2028